Skip to content

Guided Metabolic Detox Program

Effects of Standard Process's SP Detox Balance Dietary Supplements on Metabolic Detoxification

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06061289
Enrollment
32
Registered
2023-09-29
Start date
2022-03-06
Completion date
2022-09-30
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detoxification Response

Keywords

Detoxification, Whole Food Vitamins, Glutathione, liver, antioxidants, SOD, GST

Brief summary

Adequate antioxidant supply is essential for maintaining metabolic homeostasis and reducing oxidative stress during detoxification. The emerging evidence suggests that certain classes of phytonutrients can help support the detoxification process by stimulating the liver to produce detoxification enzymes or acting as antioxidants that neutralize the harmful effects of free radicals. This study was designed to examine the effects of a guided 28-day metabolic detoxification program in healthy adults. The participants were randomly assigned to consume a whole food, multi-ingredient supplement (education and intervention) or control (education and healthy meal) daily for the duration of the trial.

Detailed description

In this study, the focus is on a cohort of healthy adults enrolled in a guided detoxification program that included a healthy diet education session with or without 28-day nutritional supplementation with a whole food, proprietary multicomponent blend. The primary objective was to determine the improvement in quality of life by a validated self-reported wellness questionnaire known as Promis Global 10. The secondary outcomes were to quantify the functional markers of metabolic detoxification in blood and urine compared to the study baseline to understand the efficacy of the study formulation as part of 28-day nutritional supplementation with a whole food, proprietary multicomponent blend.

Interventions

DIETARY_SUPPLEMENTSP Detox Program

The production use and disposal of toxic chemicals and synthetic materials have increased the risk of exposure to health-threatening toxins. Causal relationships between toxic chemicals and diseases have been well established. However, many patients endure chronic symptoms that are associated with exposure to toxins before advanced stages of specific diseases are realized. Thus, there is a great demand for noninvasive laboratory tests that can provide timely assessment of chemical exposure and the capability of hepatic detoxification

Sponsors

Northwestern Health Sciences University
CollaboratorOTHER
Standard Process Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Willingness to comply with study protocol for 30 days * No allergy to any study products (check formulation section below) * Participant is over 18 years of age or older * Participant is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit, and is not actively planning a pregnancy. * Participant has at least two weeks wash out period between completion of a previous research study that required ingestion of any study food or drug and their start in the current study.

Exclusion criteria

* Prohibited Medications, Supplements or Herbal Products * Subjects who are experiencing any adverse events due to any nutraceutical, OTC, or pharmaceutical or investigational products * Celiac and other gastrointestinal health concerns * Subjects may not receive any other investigational products not part of normal clinical care * Lipid lowering drugs or the use of anticoagulant medications in the preceding 4 weeks and for duration of study * Pregnant and nursing women are excluded from participation and women of childbearing age expecting to be pregnant soon will be excluded from the study * TC levels less than 220 * Subjects with untreated endocrine, neurological, or infectious disease * Subjects with the diagnosis of HIV disease or AIDS * Significant liver or kidney disease (recent or ongoing hepatitis, cirrhosis, glomerulonephritis, dialysis treatment) * Rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, polymyositis, scleroderma, polymyalgia rheumatic, temporal arteritis or Reiter's Syndrome * Psoriasis, Deep vein thrombosis or pulmonary embolus (blood clot to lungs) * History of cancer * Serious medical illness * Substance Use - Use of ethanol within 24 hours of the evaluation visits (baseline, 4 weeks) * Any other sound medical, psychiatric and/or social reason as determined by the PI * Co-enrollment in other studies is restricted. Study staff should be notified of co-enrollment as it may require the approval of the investigator

Design outcomes

Primary

MeasureTime frameDescription
Promis Global 10 (Self- reported Wellness) Questionnaire28 daysThe PROMIS Global short form was scored into a Global Physical Health component and Global Mental Health component. The summed raw scores from PROMIS Global were converted into standardized T-score distributions such that a 50 represents the average (mean) for the US general population. A high score always represents more of the concept being measured.

Secondary

MeasureTime frameDescription
Total Serum Antioxidants28 daysTotal Antioxidant Capacity ( μM ) measured as the combined antioxidant activities of all serum constituents, including vitamins, proteins, lipids, glutathione, and uric acid. This assay will be performed using a commercial kit following manufacturer's instruction.
Detoxification Enzyme Activity - SOD28 daysAssessment of SOD activity (units/mL) using an assay that utilizes a tetrazolium salt for detection of superoxide radicals generated by xanthine oxidase and hypoxanthine using a colorimetric method.
Detoxification Enzyme Activity - GST28 daysTotal GST activity (units/mL) measured by quantifying the conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with reduced glutathione using a glutathione S-transferase assay kit
Oxidative Stress28 daysColorimetric method to study redox status of peripheral blood mononuclear cells (PBMCs) in Relative fluorescence units (RFU)
Hepatic detox marker -128 daysExcreted D-glucaric acid concentration in urine ((nM/mg)
Hepatic detox marker -228 daysExcreted Mercapturic acid concentration in urine ((μM/mM)
Total Glutathione28 daysSerum concentration of Glutathione (uM) was measured as part of a fluorometric assay.
Urinary Detox marker28 daysExcreted Porphyrins concentration in urine (nmol/mg)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026